SARS-CoV-IN-6 is a selective inhibitor of the RNA-dependent RNA polymerase (RdRp) of both SARS-CoV-1 and SARS-CoV-2, featuring an IC50 of 7.8 μM against SARS-CoV-2 RdRp. This compound effectively mitigates cytopathic effects in cells infected with SARS-CoV-1 and SARS-CoV-2 replicon-based single-round infectious particles (SRIPs). Additionally, it inhibits the expression of the SARS-CoV N protein, showing EC50 values of 0.12 µM for SARS-CoV-1 SRIPs and 1.47 µM for SARS-CoV-2 SRIPs. SARS-CoV-IN-6 is valuable for research focused on the antiviral mechanisms targeting coronavirus replication.
SARS-CoV-IN-6 is a selective inhibitor of the RNA-dependent RNA polymerase (RdRp) of both SARS-CoV-1 and SARS-CoV-2, featuring an IC50 of 7.8 μM against SARS-CoV-2 RdRp. This compound effectively mitigates cytopathic effects in cells infected with SARS-CoV-1 and SARS-CoV-2 replicon-based single-round infectious particles (SRIPs). Additionally, it inhibits the expression of the SARS-CoV N protein, showing EC50 values of 0.12 µM for SARS-CoV-1 SRIPs and 1.47 µM for SARS-CoV-2 SRIPs. SARS-CoV-IN-6 is valuable for research focused on the antiviral mechanisms targeting coronavirus replication.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
